<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01249872</url>
  </required_header>
  <id_info>
    <org_study_id>morbid obesity_post-op pain</org_study_id>
    <nct_id>NCT01249872</nct_id>
  </id_info>
  <brief_title>Patients-Controlled Epidural Analgesia After Gastric Bypass for Morbid Obesity Using Morphine-Levobupivacaine Regimens</brief_title>
  <official_title>Postoperative Thoracic Epidural Analgesia in Super Obese Patients (~BMI 60 kg m-2) Undergoing Open Weight Loss Surgery :Does the Addition of Morphine to 0.1% and 0.2% Levobupivacaine Affect Postoperative Pain Relief, Perioperative Lung Function, Return of Normal Gastrointestinal Mobility and Ambulation?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Patras</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Patras</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Adequate postoperative analgesia can facilitate recovery following gastric bypass surgery for
      morbid obesity. The efficacy and safety of intravenous patient - controlled analgesia has
      been studied, but up to date no data are available concerning the use of thoracic epidural
      patient-controlled analgesia regarding the use of levobupivacaine combined with morphine in
      morbidly obese patients. The investigators' aim in this prospective, randomized,
      double-blinded study was to compare the analgesic effectiveness, the dose requirements and
      side effects of thoracic epidural patient controlled analgesia 0.1% and 0.2% levobupivacaine
      combined with a continuous epidural administration of morphine, with or without a loading
      dose, after open gastric bypass for morbid obesity.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Morbidly obese patients (BMI &gt; 50 kg/m2) planned to undergo open variant of biliopancreatic
      diversion with Roux-en-Y gastric bypass (BPD-RYGBP) received standardized general anesthesia
      (intravenous propofol combined with remifentanyl and muscle relaxation). Preoperatively, in
      all patients an epidural catheter in the thoracic spine level will be placed between T5 and
      T8 interspace. All patients will be randomly allocated to six groups:

      Group A patients will receive intra-operatively (45 min before the estimated end of the
      surgery) a bolus dose 2 ml of normal saline, epidurally. Postoperatively, immediately after
      extubation patient controlled epidural anesthesia (PCEA)with 0.1% levobupivacaine (5ml,
      lockout interval 10min) , combined with a continuous epidural infusion of morphine 0.2 mg/h
      will be administered, Group B patients will receive an epidural bolus dose of 1mg of morphine
      intra-operatively (45 min before the estimated end of the surgery) and postoperatively the
      same levobupivacaine and morphine regimen as Group A, Group C patients will receive an
      epidural bolus dose 2 mg of morphine intra-operatively and thereafter the same
      levobupivacaine and morphine regimen as Group A.

      Group D patients will receive intra-operatively an epidural bolus dose of 2 ml of normal
      saline. Postoperatively, the patients will receive PCEA in a dose of 0.2% levobupivacaine
      (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2
      mg/h, Group E patients will receive intra-operatively an epidural bolus dose of 1mg of
      morphine intra-operatively and postoperatively the same regimen as Group D.

      Group F patients will receive intra-operatively an epidural bolus dose of 2 mg of morphine
      intra-operatively and thereafter the same regimen as Group D.

      Pain assessment will be performed using visual analogue scale (VAS, 10cm scale) at rest, at
      mobilization and at cough. Furthermore, total local anesthetic and morphine consumption, side
      effects on cardiovascular, respiratory and gastrointestinal systems, including blood
      pressure,blood gases, spirometric values Forced Expiratory Volume at 1 sec (FEV1), Forced
      Vital Capacity (FVC), Peak Expiratory Flow Rate (PEFR), incidents of postoperative nausea and
      vomiting (PONV), pruritus, time to first flatus, postoperative ambulation will be recorded
      for up to 6 days.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2010</start_date>
  <completion_date type="Actual">September 2012</completion_date>
  <primary_completion_date type="Actual">August 2012</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change From Baseline in Pain Scores (Visual Analogue Scale)</measure>
    <time_frame>up to 48 h postoperatively</time_frame>
    <description>Pain scores at rest and on cough using a 10cm Visual Analogue Scale(0=no pain, 10=worst possible pain) were assessed up to 48h postoperatively.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to Postoperative Bowel Recovery</measure>
    <time_frame>up to 6 days</time_frame>
    <description>Time to postoperative recovery of bowel function assessed by first flatus or stool, noticed by the patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to First Postoperative Ambulation</measure>
    <time_frame>up to 6 days</time_frame>
    <description>Time to being able to walk without assistance within the room or outside the room</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Consumption of Levobupivacaine at 24h and 48 h Postoperatively</measure>
    <time_frame>up to 48 hours postoperatively</time_frame>
    <description>Cumulative consumption of levobupivacaine administered via patients controlled epidural analgesia pump( PCEA) at 24h and 48 h postoperatively</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cumulative Consumption of Epidural Morphine at 24h and 48h Postoperatively</measure>
    <time_frame>up to 48 hours postoperatively</time_frame>
    <description>Cumulative consumption of epidural morphine administered as loading dose, intraoperatively, of 1mg(groups B and E)or 2mg (groups C and F) and as continuous infusion of 0,2mg/h ( all groups) at 24h and 48h postoperatively.All participants in each Group received the same dose of epidural morphine, as no participant missed a scheduled dose.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline of Spirometric Values</measure>
    <time_frame>up to 6th day postoperatively</time_frame>
    <description>Preoperatively, after a detailed demonstration, baseline spirometry measurements of forced vital capacity (FVC), forced expiratory volume in 1 s (FEV1) and peak expiratory flow rate (PEFR) were measured, using a bedside spirometer (PowerCubeΤΜ, Ganshorn Medizin Electronic, Germany), on-line connected to a PC. Spirometry was standardized with each patient in a 30o head-up position and it was performed at least three times and the best measurement was recorded, according to the criteria of the European Respiratory Society .Postoperatively, spirometric values (FVC= Forced Vital Capacity, FEV1=Forced Expiratory Volume at 1 sec , PEFR= Peak Expiratory Flow Rate)were recorded at 12, 24, 36, 48, 72, 144 hours . Data are expressed as percentage of preoperative values, which are 100%.</description>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Actual">96</enrollment>
  <condition>Morbid Obesity</condition>
  <condition>Postoperative Pain</condition>
  <condition>Postoperative Bowel Function</condition>
  <condition>Postoperative Ambulation</condition>
  <arm_group>
    <arm_group_label>GROUP A : 0 mg MORPHINE-0.1% LEVOBUPIVACAINE</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group A patients receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose 2 ml of normal saline. Postoperatively, patients receive PCEA of 0.1% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>GROUP B : 1 mg MORPHINE- 0.1% LEVOBUPIVACAINE</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group B patients receive an epidural bolus dose of 1mg of morphine intra-operatively (45 min before the estimated end of the surgery). Postoperatively, patients receive PCEA of 0.1% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h</description>
  </arm_group>
  <arm_group>
    <arm_group_label>GROUP C : 2 mg MORPHINE-0.1% LEVOBUPIVACAINE</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group C patients receive an epidural bolus dose 2 mg of morphine intra-operatively (45 min before the estimated end of the surgery).Postoperatively, patients receive PCEA of 0.1% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h</description>
  </arm_group>
  <arm_group>
    <arm_group_label>GROUP D : 0 mg MORPHINE- 0.2% LEVOBUPIVACAINE</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group D patients receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose of 2 ml of normal saline, epidurally. Postoperatively,patients receive PCEA of 0.2% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h</description>
  </arm_group>
  <arm_group>
    <arm_group_label>GROUP E : 1 mg MORPHINE-0.2 % LEVOBUPIVACAINE</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group E patients receive intra-operatively (45 min before the estimated end of the surgery) an epidural bolus dose of 1mg of morphine.Postoperatively, patients receive PCEA of 0.2% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h</description>
  </arm_group>
  <arm_group>
    <arm_group_label>GROUP F : 2 mg MORPHINE- 0.2% LEVOBUPIVACAINE</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group F patients receive intra-operatively (45 min before the estimated end of the surgery) an epidural bolus dose of 2 mg of morphine. Postoperatively, patients receive PCEA of 0.2% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>GROUP A : 0 mg MORPHINE-0.1% LEVOBUPIVACAINE</intervention_name>
    <description>Patients receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose 2 ml of normal saline, epidurally. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA) of 0.1% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
    <arm_group_label>GROUP A : 0 mg MORPHINE-0.1% LEVOBUPIVACAINE</arm_group_label>
    <other_name>Morfina cloridrato 10 mg /ml - Morphine</other_name>
    <other_name>Chirocaine 5 mg/ml - Levobupivacaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>GROUP B : 1 mg MORPHINE- 0.1% LEVOBUPIVACAINE</intervention_name>
    <description>Patients receive intraoperatively(45 min before the estimated end of the surgery)an epidural bolus dose of 1mg of morphine.Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA) of 0.1% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
    <arm_group_label>GROUP B : 1 mg MORPHINE- 0.1% LEVOBUPIVACAINE</arm_group_label>
    <other_name>Morfina cloridrato 10 mg /ml - Morphine</other_name>
    <other_name>Chirocaine 5 mg/ml - Levobupivacaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>GROUP C : 2 mg MORPHINE-0.1% LEVOBUPIVACAINE</intervention_name>
    <description>Patients receive intraoperatively (45 min before the estimated end of the surgery) a bolus dose 2 mg of morphine, epidurally. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA) of 0.1% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
    <arm_group_label>GROUP C : 2 mg MORPHINE-0.1% LEVOBUPIVACAINE</arm_group_label>
    <other_name>Morfina cloridrato 10 mg /ml - Morphine</other_name>
    <other_name>Chirocaine 5 mg/ml - Levobupivacaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>GROUP D : 0 mg MORPHINE- 0.2% LEVOBUPIVACAINE</intervention_name>
    <description>Patients receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose of 2 ml of normal saline epidurally. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA) of 0.2% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
    <arm_group_label>GROUP D : 0 mg MORPHINE- 0.2% LEVOBUPIVACAINE</arm_group_label>
    <other_name>Morfina cloridrato 10 mg /ml - Morphine</other_name>
    <other_name>Chirocaine 5 mg/ml - Levobupivacaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>GROUP E : 1 mg MORPHINE-0.2 % LEVOBUPIVACAINE</intervention_name>
    <description>Patients receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose of 1mg of morphine, epidurally.Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA) of 0.2% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
    <arm_group_label>GROUP E : 1 mg MORPHINE-0.2 % LEVOBUPIVACAINE</arm_group_label>
    <other_name>Morfina cloridrato 10 mg /ml - Morphine</other_name>
    <other_name>Chirocaine 5 mg/ml - Levobupivacaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>GROUP F : 2 mg MORPHINE- 0.2% LEVOBUPIVACAINE</intervention_name>
    <description>Patients receive an epidural bolus dose of 2 mg of morphine intra-operatively (45 min before the estimated end of the surgery).Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA) of 0.2% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
    <arm_group_label>GROUP F : 2 mg MORPHINE- 0.2% LEVOBUPIVACAINE</arm_group_label>
    <other_name>Morfina cloridrato 10 mg /ml - Morphine</other_name>
    <other_name>Chirocaine 5 mg/ml - Levobupivacaine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Body mass index (BMI) &gt; 50

          -  Age &lt; 50

          -  Patients written consent to participate in the study

        Exclusion Criteria:

          -  Cardiovascular disease (valvular and ischemic heart disease)

          -  Patients refusal to participate in the study

          -  Contraindication to epidural catheter placement (e.g anticoagulation, anti- platelets
             medication)

          -  Active psychiatric disease requiring treatment

          -  Redo surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>KRITON S FILOS, MD, PhD, PROFESSOR</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Anesthesiology and Critical Care</affiliation>
  </overall_official>
  <overall_official>
    <last_name>ATHINA SIAMPALIOTH, MD</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital of Patras</affiliation>
  </overall_official>
  <overall_official>
    <last_name>ANASTASIA ZOTOU, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital of Patras</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Patras, Department of Anesthesiology and Critical Care Medicine</name>
      <address>
        <city>Patras</city>
        <state>Achaia</state>
        <zip>26500</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 22, 2010</study_first_submitted>
  <study_first_submitted_qc>November 29, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 30, 2010</study_first_posted>
  <results_first_submitted>March 31, 2013</results_first_submitted>
  <results_first_submitted_qc>June 18, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">July 24, 2013</results_first_posted>
  <last_update_submitted>June 18, 2013</last_update_submitted>
  <last_update_submitted_qc>June 18, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 24, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Patras</investigator_affiliation>
    <investigator_full_name>Zotou Natassa,MD</investigator_full_name>
    <investigator_title>Anesthesiologist M.D, D.E.S.A.</investigator_title>
  </responsible_party>
  <keyword>open gastric by-pass</keyword>
  <keyword>super morbidly obese patients</keyword>
  <keyword>postoperative thoracic epidural analgesia</keyword>
  <keyword>different drug regimens (morphine and levobupivacaine)</keyword>
  <keyword>Lung function tests</keyword>
  <keyword>Postoperative Bowel recovery</keyword>
  <keyword>Postoperative Ambulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Obesity, Morbid</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Levobupivacaine</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Between January 2010 and September 2012, a total of 107 morbidly obese patients undergoing an open weight loss surgery (BPD-RYGBP) were assessed for eligibility, with 96 patients randomized to one of the six Groups (n=16)</recruitment_details>
      <pre_assignment_details>From the 107 patients, assessed for eligibility, 11 patients were excluded due to:
Surgery postponed (n=3)
Decline to participate (n=2)
Prolonged surgery &gt;4h, due to complications (n=3)
Failure to place epidural catheter (n=3)</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>GROUP A : 0 mg MORPHINE- 0.1% LEVOBUPIVACAINE</title>
          <description>Group A patients (n=16) receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose of 2ml of normal saline, epidurally. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA)with 0.1% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
        </group>
        <group group_id="P2">
          <title>GROUP B : 1 mg MORPHINE- 0.1%LEVOBUPIVACAINE</title>
          <description>Group B patients (n=16)receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose of 1mg of morphine, epidurally. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA)with 0.1% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
        </group>
        <group group_id="P3">
          <title>GROUP C : 2 mg MORPHINE- 0.1% LEVOBUPIVACAINE</title>
          <description>Group C patients (n=16) receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose of 2mg of morphine, epidurally. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA)with 0.1% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
        </group>
        <group group_id="P4">
          <title>GROUP D : 0 mg MORPHINE- 0.2% LEVOBUPIVACAINE</title>
          <description>Group D patients (n=16)receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose of 2ml of normal saline, epidurally. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA)with 0.2% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
        </group>
        <group group_id="P5">
          <title>GROUP E : 1 mg MORPHINE-0.2 % LEVOBUPIVACAINE</title>
          <description>Group E patients (n=16)receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose of 1mg of morphine, epidurally. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA)with 0.2% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
        </group>
        <group group_id="P6">
          <title>GROUP F : 2 mg MORPHINE- 0.2% LEVOBUPIVACAINE</title>
          <description>Group F patients (n=16) receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose of 2mg of morphine, epidurally. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA)with 0.2% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
                <participants group_id="P2" count="16"/>
                <participants group_id="P3" count="16"/>
                <participants group_id="P4" count="16"/>
                <participants group_id="P5" count="16"/>
                <participants group_id="P6" count="16"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
                <participants group_id="P2" count="16"/>
                <participants group_id="P3" count="16"/>
                <participants group_id="P4" count="16"/>
                <participants group_id="P5" count="16"/>
                <participants group_id="P6" count="16"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>GROUP A : 0 mg MORPHINE-0.1% LEVOBUPIVACAINE</title>
          <description>Group A patients (n=16) receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose 2 ml of normal saline, epidurally. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA)with 0.1% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
        </group>
        <group group_id="B2">
          <title>GROUP B : 1 mg MORPHINE- 0.1% LEVOBUPIVACAINE</title>
          <description>Group B patients (n=16) receive intraoperatively(45 min before the estimated end of the surgery) an epidural bolus dose of 1mg of morphine.Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA)with 0.1% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
        </group>
        <group group_id="B3">
          <title>GROUP C : 2 mg MORPHINE-0.1% LEVOBUPIVACAINE</title>
          <description>Group C patients (n=16) receive intraoperatively (45 min before the estimated end of the surgery) an epidural bolus dose 2 mg of morphine. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA)with 0.1% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
        </group>
        <group group_id="B4">
          <title>GROUP D : 0 mg MORPHINE- 0.2% LEVOBUPIVACAINE</title>
          <description>Group D patients (n=16) receive intra-operatively (45 min before the estimated end of the surgery) an epidural bolus dose of 2 ml of normal saline. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA)with 0.2% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
        </group>
        <group group_id="B5">
          <title>GROUP E : 1 mg MORPHINE-0.2 % LEVOBUPIVACAINE</title>
          <description>Group E patients (n=16) receive intra-operatively(45 min before the estimated end of the surgery) an epidural bolus dose of 1mg of morphine. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA)with 0.2% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
        </group>
        <group group_id="B6">
          <title>GROUP F : 2 mg MORPHINE- 0.2% LEVOBUPIVACAINE</title>
          <description>Group F patients (n=16) receive an epidural bolus dose of 2 mg of morphine intra-operatively (45 min before the estimated end of the surgery).Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA)with 0.2% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
        </group>
        <group group_id="B7">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="16"/>
            <count group_id="B2" value="16"/>
            <count group_id="B3" value="16"/>
            <count group_id="B4" value="16"/>
            <count group_id="B5" value="16"/>
            <count group_id="B6" value="16"/>
            <count group_id="B7" value="96"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="16"/>
                    <measurement group_id="B4" value="16"/>
                    <measurement group_id="B5" value="16"/>
                    <measurement group_id="B6" value="16"/>
                    <measurement group_id="B7" value="96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <title>Age (yr)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="35.1" spread="9.4"/>
                    <measurement group_id="B2" value="32.8" spread="9.5"/>
                    <measurement group_id="B3" value="34.8" spread="9.2"/>
                    <measurement group_id="B4" value="34.3" spread="8.4"/>
                    <measurement group_id="B5" value="35.8" spread="8.1"/>
                    <measurement group_id="B6" value="35.1" spread="8.5"/>
                    <measurement group_id="B7" value="34.7" spread="7.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="12"/>
                    <measurement group_id="B4" value="10"/>
                    <measurement group_id="B5" value="12"/>
                    <measurement group_id="B6" value="9"/>
                    <measurement group_id="B7" value="65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="6"/>
                    <measurement group_id="B5" value="4"/>
                    <measurement group_id="B6" value="7"/>
                    <measurement group_id="B7" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Greece</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="16"/>
                    <measurement group_id="B4" value="16"/>
                    <measurement group_id="B5" value="16"/>
                    <measurement group_id="B6" value="16"/>
                    <measurement group_id="B7" value="96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index (BMI)</title>
          <units>kg/m2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="57.8" spread="5.6"/>
                    <measurement group_id="B2" value="57.5" spread="6.0"/>
                    <measurement group_id="B3" value="58.3" spread="7.8"/>
                    <measurement group_id="B4" value="58.6" spread="6.9"/>
                    <measurement group_id="B5" value="60.0" spread="3.9"/>
                    <measurement group_id="B6" value="59.4" spread="7.0"/>
                    <measurement group_id="B7" value="58.6" spread="6.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Pain Scores (Visual Analogue Scale)</title>
        <description>Pain scores at rest and on cough using a 10cm Visual Analogue Scale(0=no pain, 10=worst possible pain) were assessed up to 48h postoperatively.</description>
        <time_frame>up to 48 h postoperatively</time_frame>
        <population>The sample size was chosen in order to detect a difference in the epidural levobupivacaine PCEA consumption at 48 hrs. We calculated that 14 patients per group would be adequate to detect statistical significance (α = 0.05, power = 90%), using data from a previous pilot study Then, we increased the sample size by 15%.</population>
        <group_list>
          <group group_id="O1">
            <title>GROUP A : 0 mg MORPHINE-0.1% LEVOBUPIVACAINE</title>
            <description>Group A patients (n=16) receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose 2 ml of normal saline, epidurally. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA)with 0.1% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
          </group>
          <group group_id="O2">
            <title>GROUP B : 1 mg MORPHINE- 0.1% LEVOBUPIVACAINE</title>
            <description>Group B patients (n=16) receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose of 1mg of morphine, epidurally. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA)with 0.1% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
          </group>
          <group group_id="O3">
            <title>GROUP C : 2 mg MORPHINE-0.1% LEVOBUPIVACAINE</title>
            <description>Group C patients (n=16)receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose of 2mg of morphine, epidurally. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA)with 0.1% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
          </group>
          <group group_id="O4">
            <title>GROUP D : 0 mg MORPHINE- 0.2% LEVOBUPIVACAINE</title>
            <description>Group D patients (n=16)receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose 2 ml of normal saline, epidurally. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA)with 0.2% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
          </group>
          <group group_id="O5">
            <title>GROUP E : 1 mg MORPHINE-0.2 % LEVOBUPIVACAINE</title>
            <description>Group E patients (n=16) receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose of 1mg of morphine, epidurally. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA)with 0.2% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
          </group>
          <group group_id="O6">
            <title>GROUP F : 2 mg MORPHINE- 0.2% LEVOBUPIVACAINE</title>
            <description>Group F patients (n=16) receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose of 2mg of morphine, epidurally. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA)with 0.2% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Pain Scores (Visual Analogue Scale)</title>
          <description>Pain scores at rest and on cough using a 10cm Visual Analogue Scale(0=no pain, 10=worst possible pain) were assessed up to 48h postoperatively.</description>
          <population>The sample size was chosen in order to detect a difference in the epidural levobupivacaine PCEA consumption at 48 hrs. We calculated that 14 patients per group would be adequate to detect statistical significance (α = 0.05, power = 90%), using data from a previous pilot study Then, we increased the sample size by 15%.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="16"/>
                <count group_id="O3" value="16"/>
                <count group_id="O4" value="16"/>
                <count group_id="O5" value="16"/>
                <count group_id="O6" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>VAS rest at 6h postoperatively</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.4" spread="2.3"/>
                    <measurement group_id="O2" value="1.6" spread="1.8"/>
                    <measurement group_id="O3" value="1.6" spread="2.0"/>
                    <measurement group_id="O4" value="0.8" spread="1.4"/>
                    <measurement group_id="O5" value="1.1" spread="1.6"/>
                    <measurement group_id="O6" value="0.8" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>VAS rest at 24h postoperatively</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1" spread="0.3"/>
                    <measurement group_id="O2" value="0.4" spread="0.9"/>
                    <measurement group_id="O3" value="0.4" spread="1.0"/>
                    <measurement group_id="O4" value="0.0" spread="0.0"/>
                    <measurement group_id="O5" value="1.8" spread="2.0"/>
                    <measurement group_id="O6" value="0.1" spread="0.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>VAS rest at 48h postoperatively</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0" spread="0.0"/>
                    <measurement group_id="O2" value="0.1" spread="0.3"/>
                    <measurement group_id="O3" value="0.4" spread="0.9"/>
                    <measurement group_id="O4" value="0.0" spread="0.0"/>
                    <measurement group_id="O5" value="0.1" spread="0.3"/>
                    <measurement group_id="O6" value="0.0" spread="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>VAS cough at 6h postoperatively</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.7" spread="2.7"/>
                    <measurement group_id="O2" value="4.2" spread="2.0"/>
                    <measurement group_id="O3" value="4.7" spread="2.7"/>
                    <measurement group_id="O4" value="3.9" spread="1.9"/>
                    <measurement group_id="O5" value="3.9" spread="1.9"/>
                    <measurement group_id="O6" value="2.7" spread="2.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>VAS cough at 24h postoperatively</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.4" spread="1.9"/>
                    <measurement group_id="O2" value="2.6" spread="1.9"/>
                    <measurement group_id="O3" value="3.2" spread="2.2"/>
                    <measurement group_id="O4" value="2.0" spread="1.8"/>
                    <measurement group_id="O5" value="3.5" spread="2.0"/>
                    <measurement group_id="O6" value="2.4" spread="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>VAS cough at 48h postoperatively</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.3" spread="1.5"/>
                    <measurement group_id="O2" value="2.4" spread="1.7"/>
                    <measurement group_id="O3" value="2.3" spread="2.3"/>
                    <measurement group_id="O4" value="1.3" spread="1.4"/>
                    <measurement group_id="O5" value="1.4" spread="1.8"/>
                    <measurement group_id="O6" value="0.8" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to Postoperative Bowel Recovery</title>
        <description>Time to postoperative recovery of bowel function assessed by first flatus or stool, noticed by the patient</description>
        <time_frame>up to 6 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>GROUP A : 0 mg MORPHINE-0.1% LEVOBUPIVACAINE</title>
            <description>Group A patients (n=16) receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose of 2ml of normal saline, epidurally. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA)with 0.1% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
          </group>
          <group group_id="O2">
            <title>GROUP B : 1 mg MORPHINE- 0.1%LEVOBUPIVACAINE</title>
            <description>Group B patients (n=16)receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose of 1mg of morphine, epidurally. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA)with 0.1% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
          </group>
          <group group_id="O3">
            <title>GROUP C : 2 mg MORPHINE-0.1% LEVOBUPIVACAINE</title>
            <description>Group C patients (n=16) receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose of 2mg of morphine, epidurally. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA)with 0.1% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
          </group>
          <group group_id="O4">
            <title>GROUP D : 0 mg MORPHINE- 0.2% LEVOBUPIVACAINE</title>
            <description>Group D patients (n=16) receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose of 2ml of normal saline, epidurally. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA)with 0.2% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
          </group>
          <group group_id="O5">
            <title>GROUP E : 1 mg MORPHINE-0.2 % LEVOBUPIVACAINE</title>
            <description>Group E patients (n=16) receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose of 1mg of morphine, epidurally. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA)with 0.2% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
          </group>
          <group group_id="O6">
            <title>GROUP F : 2 mg MORPHINE- 0.2% LEVOBUPIVACAINE</title>
            <description>Group F patients (n=16) receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose of 2mg of morphine, epidurally. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA)with 0.2% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Postoperative Bowel Recovery</title>
          <description>Time to postoperative recovery of bowel function assessed by first flatus or stool, noticed by the patient</description>
          <units>hours</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="16"/>
                <count group_id="O3" value="16"/>
                <count group_id="O4" value="16"/>
                <count group_id="O5" value="16"/>
                <count group_id="O6" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="56.6" spread="11.9"/>
                    <measurement group_id="O2" value="70.9" spread="11.9"/>
                    <measurement group_id="O3" value="67.1" spread="11.8"/>
                    <measurement group_id="O4" value="55.6" spread="12.7"/>
                    <measurement group_id="O5" value="58.6" spread="14.5"/>
                    <measurement group_id="O6" value="63.9" spread="12.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to First Postoperative Ambulation</title>
        <description>Time to being able to walk without assistance within the room or outside the room</description>
        <time_frame>up to 6 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>GROUP A : 0 mg MORPHINE-0.1% LEVOBUPIVACAINE</title>
            <description>Group A patients (n=16) receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose 2 ml of normal saline, epidurally. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA)with 0.1% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
          </group>
          <group group_id="O2">
            <title>GROUP B : 1 mg MORPHINE- 0.1% LEVOBUPIVACAINE</title>
            <description>Group B patients (n=16)receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose of 1mg of morphine, epidurally. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA)with 0.1% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
          </group>
          <group group_id="O3">
            <title>GROUP C : 2 mg MORPHINE-0.1% LEVOBUPIVACAINE</title>
            <description>Group C patients (n=16) receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose of 2mg of morphine, epidurally. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA)with 0.1% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
          </group>
          <group group_id="O4">
            <title>GROUP D : 0 mg MORPHINE- 0.2% LEVOBUPIVACAINE</title>
            <description>Group D patients (n=16) receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose of 2ml of normal saline, epidurally. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA)with 0.2% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
          </group>
          <group group_id="O5">
            <title>GROUP E : 1 mg MORPHINE-0.2 % LEVOBUPIVACAINE</title>
            <description>Group E patients (n=16) receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose of 1mg of morphine, epidurally. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA)with 0.2% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
          </group>
          <group group_id="O6">
            <title>GROUP F : 2 mg MORPHINE- 0.2% LEVOBUPIVACAINE</title>
            <description>Group F patients (n=16) receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose of 2mg of morphine, epidurally. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA)with 0.2% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
          </group>
        </group_list>
        <measure>
          <title>Time to First Postoperative Ambulation</title>
          <description>Time to being able to walk without assistance within the room or outside the room</description>
          <units>hours</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="16"/>
                <count group_id="O3" value="16"/>
                <count group_id="O4" value="16"/>
                <count group_id="O5" value="16"/>
                <count group_id="O6" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Walking in the room unassisted</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.0" spread="4.1"/>
                    <measurement group_id="O2" value="19.9" spread="3.4"/>
                    <measurement group_id="O3" value="19.1" spread="3.5"/>
                    <measurement group_id="O4" value="20.7" spread="4.6"/>
                    <measurement group_id="O5" value="21.4" spread="1.9"/>
                    <measurement group_id="O6" value="20.6" spread="3.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Walking out of the room unassisted</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33.3" spread="12.1"/>
                    <measurement group_id="O2" value="47.0" spread="11.1"/>
                    <measurement group_id="O3" value="43.3" spread="11.1"/>
                    <measurement group_id="O4" value="39.5" spread="14.0"/>
                    <measurement group_id="O5" value="43.4" spread="11.6"/>
                    <measurement group_id="O6" value="45.1" spread="10.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Consumption of Levobupivacaine at 24h and 48 h Postoperatively</title>
        <description>Cumulative consumption of levobupivacaine administered via patients controlled epidural analgesia pump( PCEA) at 24h and 48 h postoperatively</description>
        <time_frame>up to 48 hours postoperatively</time_frame>
        <group_list>
          <group group_id="O1">
            <title>GROUP A : 0 mg MORPHINE-0.1% LEVOBUPIVACAINE</title>
            <description>Group A patients (n=16) receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose 2 ml of normal saline, epidurally. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA)with 0.1% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
          </group>
          <group group_id="O2">
            <title>GROUP B : 1 mg MORPHINE- 0.1% LEVOBUPIVACAINE</title>
            <description>Group B patients (n=16) receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose of 1mg of morphine, epidurally. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA)with 0.1% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
          </group>
          <group group_id="O3">
            <title>GROUP C : 2 mg MORPHINE-0.1% LEVOBUPIVACAINE</title>
            <description>Group C patients (n=16) receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose of 2mg of morphine, epidurally. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA)with 0.1% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
          </group>
          <group group_id="O4">
            <title>GROUP D : 0 mg MORPHINE- 0.2% LEVOBUPIVACAINE</title>
            <description>Group D patients (n=16)receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose of 2ml of normal saline, epidurally. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA)with 0.2% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
          </group>
          <group group_id="O5">
            <title>GROUP E : 1 mg MORPHINE-0.2 % LEVOBUPIVACAINE</title>
            <description>Group E patients (n=16) receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose of 1mg of morphine, epidurally. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA)with 0.2% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
          </group>
          <group group_id="O6">
            <title>GROUP F : 2 mg MORPHINE- 0.2% LEVOBUPIVACAINE</title>
            <description>Group F patients (n=16)receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose of 2mg of morphine, epidurally. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA)with 0.2% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
          </group>
        </group_list>
        <measure>
          <title>Consumption of Levobupivacaine at 24h and 48 h Postoperatively</title>
          <description>Cumulative consumption of levobupivacaine administered via patients controlled epidural analgesia pump( PCEA) at 24h and 48 h postoperatively</description>
          <units>mg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="16"/>
                <count group_id="O3" value="16"/>
                <count group_id="O4" value="16"/>
                <count group_id="O5" value="16"/>
                <count group_id="O6" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Levobupivacaine consumption at 24h postoperatively</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="132.9" spread="58.9"/>
                    <measurement group_id="O2" value="178.8" spread="90.1"/>
                    <measurement group_id="O3" value="165.6" spread="92.9"/>
                    <measurement group_id="O4" value="325.7" spread="147.2"/>
                    <measurement group_id="O5" value="241.9" spread="145.0"/>
                    <measurement group_id="O6" value="203.1" spread="115.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Levobupivacaine consumption at 48h postoperatively</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="189.8" spread="117.5"/>
                    <measurement group_id="O2" value="240.9" spread="133.0"/>
                    <measurement group_id="O3" value="231.9" spread="139.2"/>
                    <measurement group_id="O4" value="435.4" spread="220.2"/>
                    <measurement group_id="O5" value="351.3" spread="193.6"/>
                    <measurement group_id="O6" value="294.7" spread="158.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cumulative Consumption of Epidural Morphine at 24h and 48h Postoperatively</title>
        <description>Cumulative consumption of epidural morphine administered as loading dose, intraoperatively, of 1mg(groups B and E)or 2mg (groups C and F) and as continuous infusion of 0,2mg/h ( all groups) at 24h and 48h postoperatively.All participants in each Group received the same dose of epidural morphine, as no participant missed a scheduled dose.</description>
        <time_frame>up to 48 hours postoperatively</time_frame>
        <group_list>
          <group group_id="O1">
            <title>GROUP A : 0 mg MORPHINE-0.1% LEVOBUPIVACAINE</title>
            <description>Group A patients (n=16) receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose 2 ml of normal saline, epidurally. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA)with 0.1% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
          </group>
          <group group_id="O2">
            <title>GROUP B : 1 mg MORPHINE- 0.1% LEVOBUPIVACAINE</title>
            <description>Group B patients (n=16)receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose of 1mg of morphine, epidurally. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA)with 0.1% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
          </group>
          <group group_id="O3">
            <title>GROUP C : 2 mg MORPHINE-0.1% LEVOBUPIVACAINE</title>
            <description>Group C patients (n=16) receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose of 2mg of morphine, epidurally. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA)with 0.1% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
          </group>
          <group group_id="O4">
            <title>GROUP D : 0 mg MORPHINE- 0.2% LEVOBUPIVACAINE</title>
            <description>Group D patients (n=16) receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose of 2ml of normal saline, epidurally. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA)with 0.2% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
          </group>
          <group group_id="O5">
            <title>GROUP E : 1 mg MORPHINE-0.2 % LEVOBUPIVACAINE</title>
            <description>Group E patients (n=16)receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose of 1mg of morphine, epidurally. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA)with 0.2% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
          </group>
          <group group_id="O6">
            <title>GROUP F : 2 mg MORPHINE- 0.2% LEVOBUPIVACAINE</title>
            <description>Group F patients (n=16) receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose of 2mg of morphine, epidurally. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA)with 0.2% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
          </group>
        </group_list>
        <measure>
          <title>Cumulative Consumption of Epidural Morphine at 24h and 48h Postoperatively</title>
          <description>Cumulative consumption of epidural morphine administered as loading dose, intraoperatively, of 1mg(groups B and E)or 2mg (groups C and F) and as continuous infusion of 0,2mg/h ( all groups) at 24h and 48h postoperatively.All participants in each Group received the same dose of epidural morphine, as no participant missed a scheduled dose.</description>
          <units>mg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="16"/>
                <count group_id="O3" value="16"/>
                <count group_id="O4" value="16"/>
                <count group_id="O5" value="16"/>
                <count group_id="O6" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Epidural morphine consumption at 24h postoperative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.8" spread="0.0"/>
                    <measurement group_id="O2" value="5.8" spread="0.0"/>
                    <measurement group_id="O3" value="6.8" spread="0.0"/>
                    <measurement group_id="O4" value="4.8" spread="0.0"/>
                    <measurement group_id="O5" value="5.8" spread="0.0"/>
                    <measurement group_id="O6" value="6.8" spread="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Epidural morphine consumption at 48h postoperative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.6" spread="0.0"/>
                    <measurement group_id="O2" value="10.6" spread="0.0"/>
                    <measurement group_id="O3" value="11.6" spread="0.0"/>
                    <measurement group_id="O4" value="9.6" spread="0.0"/>
                    <measurement group_id="O5" value="10.6" spread="0.0"/>
                    <measurement group_id="O6" value="11.6" spread="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline of Spirometric Values</title>
        <description>Preoperatively, after a detailed demonstration, baseline spirometry measurements of forced vital capacity (FVC), forced expiratory volume in 1 s (FEV1) and peak expiratory flow rate (PEFR) were measured, using a bedside spirometer (PowerCubeΤΜ, Ganshorn Medizin Electronic, Germany), on-line connected to a PC. Spirometry was standardized with each patient in a 30o head-up position and it was performed at least three times and the best measurement was recorded, according to the criteria of the European Respiratory Society .Postoperatively, spirometric values (FVC= Forced Vital Capacity, FEV1=Forced Expiratory Volume at 1 sec , PEFR= Peak Expiratory Flow Rate)were recorded at 12, 24, 36, 48, 72, 144 hours . Data are expressed as percentage of preoperative values, which are 100%.</description>
        <time_frame>up to 6th day postoperatively</time_frame>
        <group_list>
          <group group_id="O1">
            <title>GROUP A : 0 mg MORPHINE-0.1% LEVOBUPIVACAINE</title>
            <description>Group A patients (n=16) receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose 2 ml of normal saline, epidurally. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA)with 0.1% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
          </group>
          <group group_id="O2">
            <title>GROUP B : 1 mg MORPHINE- 0.1% LEVOBUPIVACAINE</title>
            <description>Group B patients (n=16) receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose of 1mg of morphine, epidurally. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA)with 0.1% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
          </group>
          <group group_id="O3">
            <title>GROUP C : 2 mg MORPHINE-0.1% LEVOBUPIVACAINE</title>
            <description>Group C patients (n=16) receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose of 2mg of morphine, epidurally. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA)with 0.1% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
          </group>
          <group group_id="O4">
            <title>GROUP D : 0 mg MORPHINE- 0.2% LEVOBUPIVACAINE</title>
            <description>Group D patients (n=16) receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose of 2ml of normal saline, epidurally. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA)with 0.2% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
          </group>
          <group group_id="O5">
            <title>GROUP E : 1 mg MORPHINE-0.2 % LEVOBUPIVACAINE</title>
            <description>Group E patients (n=16)receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose of 1mg of morphine, epidurally. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA)with 0.2% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
          </group>
          <group group_id="O6">
            <title>GROUP F : 2 mg MORPHINE- 0.2% LEVOBUPIVACAINE</title>
            <description>Group F patients (n=16) receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose of 2mg of morphine, epidurally. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA)with 0.2% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline of Spirometric Values</title>
          <description>Preoperatively, after a detailed demonstration, baseline spirometry measurements of forced vital capacity (FVC), forced expiratory volume in 1 s (FEV1) and peak expiratory flow rate (PEFR) were measured, using a bedside spirometer (PowerCubeΤΜ, Ganshorn Medizin Electronic, Germany), on-line connected to a PC. Spirometry was standardized with each patient in a 30o head-up position and it was performed at least three times and the best measurement was recorded, according to the criteria of the European Respiratory Society .Postoperatively, spirometric values (FVC= Forced Vital Capacity, FEV1=Forced Expiratory Volume at 1 sec , PEFR= Peak Expiratory Flow Rate)were recorded at 12, 24, 36, 48, 72, 144 hours . Data are expressed as percentage of preoperative values, which are 100%.</description>
          <units>percentage of preoperative values</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="16"/>
                <count group_id="O3" value="16"/>
                <count group_id="O4" value="16"/>
                <count group_id="O5" value="16"/>
                <count group_id="O6" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>FVC at 12h postoperatively</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63.2" spread="15.2"/>
                    <measurement group_id="O2" value="69.3" spread="13.1"/>
                    <measurement group_id="O3" value="68.3" spread="15.9"/>
                    <measurement group_id="O4" value="71.7" spread="14.0"/>
                    <measurement group_id="O5" value="66.4" spread="11.3"/>
                    <measurement group_id="O6" value="66.8" spread="14.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>FVC at 24h postoperatively</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62.5" spread="15.6"/>
                    <measurement group_id="O2" value="62.2" spread="13.7"/>
                    <measurement group_id="O3" value="72.1" spread="15.5"/>
                    <measurement group_id="O4" value="66.8" spread="15.6"/>
                    <measurement group_id="O5" value="63.3" spread="12.1"/>
                    <measurement group_id="O6" value="62.6" spread="12.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>FVC at 36h postoperatively</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="65.7" spread="13.6"/>
                    <measurement group_id="O2" value="61.2" spread="13.8"/>
                    <measurement group_id="O3" value="65.2" spread="15.5"/>
                    <measurement group_id="O4" value="63.9" spread="13.4"/>
                    <measurement group_id="O5" value="62.8" spread="14.6"/>
                    <measurement group_id="O6" value="63.2" spread="9.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>FVC at 48h postoperatively</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63.9" spread="15.0"/>
                    <measurement group_id="O2" value="66.2" spread="12.5"/>
                    <measurement group_id="O3" value="67.6" spread="13.4"/>
                    <measurement group_id="O4" value="69.8" spread="10.1"/>
                    <measurement group_id="O5" value="71.1" spread="15.0"/>
                    <measurement group_id="O6" value="66.9" spread="10.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>FVC at 72h postoperatively</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69.4" spread="7.0"/>
                    <measurement group_id="O2" value="71.3" spread="11.8"/>
                    <measurement group_id="O3" value="76.2" spread="16.8"/>
                    <measurement group_id="O4" value="72.4" spread="10.9"/>
                    <measurement group_id="O5" value="77.3" spread="15.1"/>
                    <measurement group_id="O6" value="76.7" spread="9.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>FVC at 6th day postoperatively</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79.0" spread="18.3"/>
                    <measurement group_id="O2" value="83.9" spread="7.6"/>
                    <measurement group_id="O3" value="83.1" spread="8.0"/>
                    <measurement group_id="O4" value="84.0" spread="11.5"/>
                    <measurement group_id="O5" value="80.0" spread="18.2"/>
                    <measurement group_id="O6" value="89.2" spread="9.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>FEV1 at 12h postoperatively</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55.8" spread="19.3"/>
                    <measurement group_id="O2" value="63.9" spread="11.7"/>
                    <measurement group_id="O3" value="60.5" spread="15.3"/>
                    <measurement group_id="O4" value="65.2" spread="15.1"/>
                    <measurement group_id="O5" value="62.0" spread="9.3"/>
                    <measurement group_id="O6" value="62.1" spread="18.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>FEV1 at 24h postoperatively</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="61.5" spread="17.1"/>
                    <measurement group_id="O2" value="55.2" spread="18.4"/>
                    <measurement group_id="O3" value="71.0" spread="15.0"/>
                    <measurement group_id="O4" value="63.8" spread="16.4"/>
                    <measurement group_id="O5" value="56.4" spread="14.8"/>
                    <measurement group_id="O6" value="59.8" spread="12.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>FEV1 at 36h postoperatively</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62.9" spread="15.4"/>
                    <measurement group_id="O2" value="52.7" spread="16.4"/>
                    <measurement group_id="O3" value="61.0" spread="16.2"/>
                    <measurement group_id="O4" value="58.4" spread="14.2"/>
                    <measurement group_id="O5" value="61.1" spread="16.3"/>
                    <measurement group_id="O6" value="59.3" spread="11.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>FEV1 at 48h postoperatively</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="64.9" spread="18.1"/>
                    <measurement group_id="O2" value="55.9" spread="22.5"/>
                    <measurement group_id="O3" value="68.2" spread="19.6"/>
                    <measurement group_id="O4" value="61.8" spread="8.8"/>
                    <measurement group_id="O5" value="67.1" spread="12.6"/>
                    <measurement group_id="O6" value="64.9" spread="11.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>FEV1 at 72h postoperatively</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79.0" spread="26.1"/>
                    <measurement group_id="O2" value="70.2" spread="15.0"/>
                    <measurement group_id="O3" value="75.4" spread="8.5"/>
                    <measurement group_id="O4" value="70.2" spread="15.0"/>
                    <measurement group_id="O5" value="75.3" spread="8.5"/>
                    <measurement group_id="O6" value="72.5" spread="10.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>FEV1 at 6th day postoperatively</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86.8" spread="23.5"/>
                    <measurement group_id="O2" value="81.8" spread="7.9"/>
                    <measurement group_id="O3" value="88.0" spread="12.9"/>
                    <measurement group_id="O4" value="83.4" spread="12.0"/>
                    <measurement group_id="O5" value="79.4" spread="15.9"/>
                    <measurement group_id="O6" value="83.8" spread="8.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PEFR at 12h postoperatively</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62.9" spread="32.3"/>
                    <measurement group_id="O2" value="67.6" spread="21.1"/>
                    <measurement group_id="O3" value="61.8" spread="20.9"/>
                    <measurement group_id="O4" value="60.0" spread="22.8"/>
                    <measurement group_id="O5" value="77.9" spread="22.6"/>
                    <measurement group_id="O6" value="67.2" spread="25.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PEFR at 24h postoperatively</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="68.5" spread="21.8"/>
                    <measurement group_id="O2" value="55.6" spread="21.3"/>
                    <measurement group_id="O3" value="79.9" spread="14.3"/>
                    <measurement group_id="O4" value="70.1" spread="13.6"/>
                    <measurement group_id="O5" value="57.7" spread="22.0"/>
                    <measurement group_id="O6" value="68.9" spread="12.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PEFR at 36h postoperatively</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69.6" spread="22.0"/>
                    <measurement group_id="O2" value="57.9" spread="27.8"/>
                    <measurement group_id="O3" value="68.8" spread="20.6"/>
                    <measurement group_id="O4" value="59.4" spread="18.0"/>
                    <measurement group_id="O5" value="73.8" spread="25.6"/>
                    <measurement group_id="O6" value="67.9" spread="20.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PEFR at 48h postoperatively</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="70.7" spread="27.4"/>
                    <measurement group_id="O2" value="58.8" spread="29.2"/>
                    <measurement group_id="O3" value="79.7" spread="25.8"/>
                    <measurement group_id="O4" value="64.9" spread="17.7"/>
                    <measurement group_id="O5" value="76.4" spread="23.6"/>
                    <measurement group_id="O6" value="74.3" spread="11.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PEFR at 72h postoperatively</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77.3" spread="26.5"/>
                    <measurement group_id="O2" value="78.1" spread="32.0"/>
                    <measurement group_id="O3" value="91.3" spread="35.0"/>
                    <measurement group_id="O4" value="70.7" spread="15.1"/>
                    <measurement group_id="O5" value="80.9" spread="19.3"/>
                    <measurement group_id="O6" value="86.0" spread="28.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PEFR at 6th day postoperatively</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93.8" spread="31.5"/>
                    <measurement group_id="O2" value="98.4" spread="34.6"/>
                    <measurement group_id="O3" value="96.4" spread="15.3"/>
                    <measurement group_id="O4" value="76.3" spread="16.1"/>
                    <measurement group_id="O5" value="83.7" spread="20.5"/>
                    <measurement group_id="O6" value="89.6" spread="19.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse effects (opioid or epidural related) were assessed during the in hospital postoperative period (6days)</time_frame>
      <desc>Clinical observation and reported by the patient</desc>
      <group_list>
        <group group_id="E1">
          <title>GROUP A : 0 mg MORPHINE-0.1% LEVOBUPIVACAINE</title>
          <description>Group A patients (n=16) receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose 2 ml of normal saline, epidurally. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA)with 0.1% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
        </group>
        <group group_id="E2">
          <title>GROUP B : 1 mg MORPHINE- 0.1% LEVOBUPIVACAINE</title>
          <description>Group B patients (n=16) receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose of 1mg of morphine, epidurally. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA)with 0.1% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
        </group>
        <group group_id="E3">
          <title>GROUP C : 2 mg MORPHINE-0.1% LEVOBUPIVACAINE</title>
          <description>Group C patients (n=16) receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose of 2mg of morphine, epidurally. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA)with 0.1% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
        </group>
        <group group_id="E4">
          <title>GROUP D : 0 mg MORPHINE- 0.2% LEVOBUPIVACAINE</title>
          <description>Group D patients (n=16) receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose of 2ml of normal saline, epidurally. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA)with 0.2% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
        </group>
        <group group_id="E5">
          <title>GROUP E : 1 mg MORPHINE-0.2 % LEVOBUPIVACAINE</title>
          <description>Group E patients (n=16) receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose of 1mg of morphine, epidurally. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA)with 0.2% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
        </group>
        <group group_id="E6">
          <title>GROUP F : 2 mg MORPHINE- 0.2% LEVOBUPIVACAINE</title>
          <description>Group F patients (n=16)receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose of 2mg of morphine, epidurally. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA)with 0.2% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="16"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="16"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="16"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Postoperative nausia and vomiting</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="16"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E5" events="2" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Postoperative pruritus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="16"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="16"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="16"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Patients in groups A and D did not receive epidural morphine intraoperatively.
We excluded patients aged &gt; 50 yr as increasing the age of morbidly obese patients, might have increased the risk of perioperative complications</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr Anastasia Zotou</name_or_title>
      <organization>University Hospital Of Patras, Greece</organization>
      <phone>0026130603341</phone>
      <email>anzotou@hotmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

